Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lurasidone – Treatment for Schizophrenia and Bipolar Disorder

Drug (brand / generic)

Lurasidone / SM-13496

Company / Licensee

Dainippon Sumitomo Pharma

Therapy Class

Atypical antipsychotic agent

Product Description

Dopamine-2, serotonin-2A, serotonin-7, serotonin-1A and noradrenaline-2c receptor antagonist

Current Indication

Schizophrenia

Market Sector

CNS

Development Status

Pre-approval
Expand

Go Top